Has Lindsay Jones, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,384 in general payments to Lindsay Jones, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lindsay Jones, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lindsay Jones, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lindsay Jones, MD

Plastic and Reconstructive Surgery · Alexandria, VANPI 1609213198

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Smith+Nephew at 25.8% of the total. Reporting peaked in 2021 at $679 and has fallen 71.9% since, to $191 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in VA, where the typical reported total is $2,384.

$2,384in general payments, 2019–2025

Across 24 payments — averaging $99.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$616
Sientra, Inc.$436
AbbVie$264
Access Pro Medical, LLC$191
Integra Lifesciences Corporation$143
Baxter Healthcare$133
plus $602 from 7 others

What the payments were for

Food & beverage$2,384100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	6	$616
Sientra, Inc.	5	$436
AbbVie	2	$264
Access Pro Medical, LLC	1	$191
Integra Lifesciences Corporation	2	$143
Baxter Healthcare	1	$133
Mentor Worldwide LLC	1	$125
Avita Medical Americas, LLC	1	$118
Musculoskeletal Transplant Foundation Inc.	1	$108
Regeneron Healthcare Solutions, Inc.	1	$108
Stryker	1	$105
Galderma Laboratories, L.p.	1	$20
Bard Peripheral Vascular, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$311
GRAFIX PL$270
Stravix$270
NATRELLE$264
Matriderm$191
No Related Product$133
MENTOR MemoryShape Breast Implant$125
MENTOR MemoryGel Resterilizable Gel Sizer$125
MENTOR CPX 2 Breast Tissue Expander$125
MENTOR SILTEX Round SPECTRUM$125
RECELL$118
RENASYS TOUCH$114
SPY TECHNOLOGY$105

How this compares

$2,384 in reported general payments places this provider in the 50th percentile of 77 plastic and reconstructive surgery providers in Virginia.

See all plastic and reconstructive surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$20,054

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	12	$39
Ondansetron OdtOndansetron	11	$38
Gabapentin	12	$22

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Alexandria

Clarisa HammerAlexandria$5K
Reza KordestaniAlexandria$3K
Susan BuenaventuraAlexandria$1K
Rachel ParkAlexandria$891
Maurice NahabedianMc Lean$828K
Mark VenturiMc Lean$356K
Neil ZemmelRichmond$38K
Lauren NigroRichmond$28K
Burton SundinRichmond$23K
Vinod ChopraChantilly$19K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →